NCT00966004View on ClinicalTrials.gov

A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder

PHASE3CompletedINTERVENTIONAL
Enrollment

1,139

Participants

Timeline

Start Date

July 24, 2009

Primary Completion Date

February 15, 2010

Study Completion Date

February 15, 2010

Conditions
Urinary Bladder, Overactive
Interventions
DRUG

YM178

oral

DRUG

Placebo

oral

DRUG

tolterodine

oral

Trial Locations (4)

Unknown

Chūbu

Kantou

Kinki

Kyushu

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY